Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Darr

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Cancer Research : MCR|November 15, 2017
Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT SignalingEmily M Cousins, Dennis Goldfarb, Feng Yan, et al.
Plos One|June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimusSharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Oncotarget|December 20, 2017
Differential response to exercise in claudin-low breast cancerOliver K Glass, Michelle Bowie, Julie Fuller, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Therapeutic Advances in Medical Oncology|November 4, 2021
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse modelLauren S L Price, Judith N Rivera, Andrew J Madden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
ACS Chemical Biology|January 20, 2017
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in VivoLauren B Crowe, Philip F Hughes, David A Alcorta, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Molecular Cancer Therapeutics|April 1, 2015
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast CancerOlga Karginova, Marni B Siegel, Amanda E D Van Swearingen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Cancer Research : MCR|November 15, 2017
Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT SignalingEmily M Cousins, Dennis Goldfarb, Feng Yan, et al.
Plos One|June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimusSharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Oncotarget|December 20, 2017
Differential response to exercise in claudin-low breast cancerOliver K Glass, Michelle Bowie, Julie Fuller, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Therapeutic Advances in Medical Oncology|November 4, 2021
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse modelLauren S L Price, Judith N Rivera, Andrew J Madden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
ACS Chemical Biology|January 20, 2017
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in VivoLauren B Crowe, Philip F Hughes, David A Alcorta, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Molecular Cancer Therapeutics|April 1, 2015
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast CancerOlga Karginova, Marni B Siegel, Amanda E D Van Swearingen, et al.
Pageof 2